Acne lasers: AviClear and Accure

Promising. The data are young and industry-funded, and 'cure' belongs to the press release, not the papers. Prospective, manufacturer-supported studies report sustained reduction in inflammatory lesions at one and two years after three sessions, across skin types, with pain during treatment the main limitation.

Verdict

Promising Plausible mechanism and early evidence. Reasonable to try with realistic expectations.

Evidence base

4 PubMed-indexed studies cited below (cohort, review); no systematic review or randomised trial on the claim itself.

Suits

Moderate to severe inflammatory acne in people who cannot or will not take systemic medication, including darker skin types, after a dermatological assessment.

Not for

Comedonal acne, acne driven by an untreated hormonal or medication cause, active cystic flares needing medical control first, and anyone promised a cure.

In Singapore

AviClear is available in a small number of Singapore clinics; confirm the device's HSA registration with the provider, and note that Accure's availability here is limited.

Category

Lasers

Reviewed

1 October 2026 by Aesthetics International. Revised as evidence and regulation change.

• Praisefewer deep inflammatory breakouts six to twelve months after the course, in people who had tried everything else.
• Complaintsignificant pain during sessions and a purge of breakouts in the weeks afterwards.
• Complaintcost of a three-session course that insurance does not cover and that may still need maintenance.
• Common misconceptionthat it is a cure; published data show reduction over one to two years, not elimination.

Paraphrased from public discussion on TikTok, Instagram, Reddit and in the press. Not testimonials, and not about any one clinic. Reported in: sfstandard.com, marieclaire.com, realself.com.

1. cohort

   In a prospective industry-supported study, three sessions of 1726 nm laser reduced inflammatory acne lesions with improvement maintained over a year across skin types.

   Novel 1726 nm laser demonstrates durable therapeutic outcomes and tolerability for moderate-to-severe acne across skin types. — J Am Acad Dermatol, 2023. PMID 37328000.

2. cohort

   A prospective multicentre study reported sustained lesion reduction at twelve months after three treatments, with transient side effects.

   Safe and effective acne treatment across skin types with a 1726 nm sebum-selective laser: One year data from a prospective multicenter study. — J Am Acad Dermatol, 2026. PMID 41052654.

3. review

   The review summarised the sebaceous-selective mechanism and early clinical data for both 1726 nm platforms, noting the absence of comparative trials.

   1726 nm Lasers for the Treatment of Acne Vulgaris. — Skin Therapy Lett, 2024. PMID 38271552.

4. review

   Sebaceous-gland photothermolysis is a plausible, durable approach to acne; the authors call for independent randomised comparisons with standard therapy.

   Targeting sebaceous glands: a review of selective photothermolysis for Acne Vulgaris treatment. — Arch Dermatol Res, 2024. PMID 38850426.

Studies are selected for relevance and quality, not for agreement with the verdict; PubMed records are linked so the reader can check them.

The two reviewed treatments most often weighed against Acne lasers, on the same standard.

Aesthetics International (2026). Acne lasers: AviClear and Accure: does it work? Evidence, risks and verdict. https://aesthetics-international.org/treatments/acne-lasers-aviclear-accure/ (reviewed 1 October 2026).

Editorial, unpaid and independent of any manufacturer. Verdict: Promising. See what works and what doesn't across all 153 reviews. Spotted an error or a newer study? Suggest a correction — changes are logged on the corrections page. Terms are defined in the glossary.